Article Data

  • Views 2783
  • Dowloads 196

Case Reports

Open Access

Individual management of cervical cancer during pregnancy

  • Yan Qin Zhang1
  • Di Wu1
  • Meng Qi Deng1
  • Xiang Yu Chang1
  • XXX1
  • Jin Wei Miao1,*,
  • Yu Mei Wu1

1Department of Gynecologic Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, 100006, P. R. China

DOI: 10.31083/j.ejgo.2020.05.5214 Vol.41,Issue 5,October 2020 pp.833-837

Submitted: 31 March 2019 Accepted: 05 June 2019

Published: 15 October 2020

*Corresponding Author(s): Jin Wei Miao E-mail: miaojinweigyn@163.com

Abstract

The exact definition of cervical cancer during pregnancy has not yet been unified. Cervical cancer during pregnancy refering to cervical cancer found during pregnancy is widely accepted. With the phenomenon of late marriage and late childbearing globally, the incidence of cervical cancer during pregnancy is also increasing. Even though early screening for cervical cancer has had an enormous impact on incidence and mortality from cervical cancer worldwide, cervical cancer during pregnancy is still a major clinical problem due to the negligence and misunderstanding of early symptoms. At present, there is no global guideline for the treatment of cervical cancer during pregnancy. The clinicians can only treat according to there own experience and the patient’s wishes. Here, we provide five cases of cervical cancer during pregnancy in our hospital.


Keywords

Cervical cancer during pregnancy; Treatment; Chemotherapy; Case.


Cite and Share

Yan Qin Zhang,Di Wu,Meng Qi Deng,Xiang Yu Chang,XXX,Jin Wei Miao,Yu Mei Wu. Individual management of cervical cancer during pregnancy. European Journal of Gynaecological Oncology. 2020. 41(5);833-837.

References

[1] Gustafsson L., Pontén J., Bergstrôm R., Adami H.: “International incidence rates of invasive cervical cancer before cytological screening”. Int. J. Cancer, 1997, 71, 159-165.

[2] Eibye S., Kjær S.K., Mellemkjær L.: “Incidence of Pregnancy-Associated Cancer in Denmark, 1977–2006”. Obstetrics & Gynecology, 2013, 122, 608-617.

[3] Frédéric, A., Fumagalli, M., Dahl, S.K., Lok, C., Van, C.K., Han, S. D., et al.: ”Gynecologic cancers in pregnancy: guidelines of a second international consensus meeting. Department of Oncology, Katholieke Universiteit Leuven and Gynecologic Oncology, University Hospitals Leuven”. Int. J. Gynecol. Cancer., 2014, 24, 394.

[4] Traen K., Svane D., Kryger-Baggesen N., Bertelsen K., Mogensen O.: “Stage Ib cervical cancer during pregnancy: planned delay in treatmentcase report”. Eur. J. Gynaecol. Oncol., 2006, 27, 615-617.

[5] Demeter A., Sziller I., Csapó Z., Szánthó A., Papp Z.: “Outcome of pregnancies after cold-knife conization of the uterine cervix during pregnancy”. Eur. J. Gynaecol. Oncol., 2002, 23, 207-210.

[6] Germann N., Haie-Meder C., Morice P., Lhomme C., Duvillard P., Hacene K., et al.: “Management and clinical outcomes of pregnant patients with invasive cervical cancer”. Ann. Oncol., 2005, 16, 397-402.

[7] Van Calsteren K., Vergote I., Amant F.: “Cervical neoplasia during pregnancy: Diagnosis, management and prognosis”. Best Practice & Research Clinical Obstetrics & Gynaecology, 2005, 19, 611-630.

[8] Broders A.C.: “EPITHELIOMA OF THE GENITO-URINARY ORGANS”. Ann. Surg., 1922, 75, 574-604.

[9] Hacker N.F.: “Revised FIGO staging for carcinoma of the vulva”. International Journal of Gynecology & Obstetrics, 2009, 105, 105-106.

[10] Germann N., Haie-Meder C., Morice P., Lhomme C., Duvillard P., Hacene K., et al.: “Management and clinical outcomes of pregnant patients with invasive cervical cancer”. Ann. Oncol., 2005, 16, 397-402.

[11] Kyrgiou M., Tsoumpou I., Vrekoussis T., Martin-Hirsch P., Arbyn M., Prendiville W., et al.: “The up-to-date evidence on colposcopy practice and treatment of cervical intraepithelial neoplasia: The cochrane colposcopy & cervical cytopathology collaborative group (C5 group) approach”. Cancer Treat. Rev., 2006, 32, 516-523.

[12] Van Calsteren K., Vergote I., Amant F.: “Cervical neoplasia during pregnancy: Diagnosis, management and prognosis”. Best Practice & Research Clinical Obstetrics & Gynaecology, 2005, 19, 611-630.

[13] Van Calsteren K., Vergote I., Amant F.: “Cervical neoplasia during pregnancy: Diagnosis, management and prognosis”. Best Practice & Research Clinical Obstetrics & Gynaecology, 2005, 19, 611-630.

[14] Zagouri F., Sergentanis T.N., Chrysikos D., Bartsch R.: “Platinum Derivatives During Pregnancy in Cervical Cancer”. Obstetrics & Gynecology, 2013, 121, 337-343.

[15] Köhler C., Oppelt P., Favero G., Morgenstern B., Runnebaum I., Tsunoda A., et al.: “How much platinum passes the placental barrier? Analysis of platinum applications in 21 patients with cervical cancer during pregnancy”. am. J. Obstet. Gynecol., 2015, 213, 206. e1-206.e5.

[16] Amant F., Van Calsteren K., Halaska M.J., Beijnen J., Lagae L., Hanssens M., et al.: “Gynecologic Cancers in Pregnancy”. Int. J. Gynecol. Cancer, 2009, 19, S1-S12.

[17] Woodrow N., Permezel M., Butter-field L., Rome R., Tan J., Quinn M.: “Abnormal Cervical Cytology in Pregnancy: Experience of 811 Cases”. the Australian and New Zealand Journal of Obstetrics and Gynaecology, 1998, 38, 161-165.


Submission Turnaround Time

Top